MC38-Stk11 KO
Strain Information
Validation Data
Fig1. Stk11 expression on in vitro cultured cells of MC38-Stk11-KO.
Fig2. In vivo validation of MC38-Stk11-KO in C57BL/6 mice. C57BL/6 mice were inoculated with MC38-Stk11-KO subcutaneously at 1×106 cells/mouse inoculum for tumor development. The day of vaccination for mice is defined as Day 0, and tumor measurement and weight measurement begin on the 3rd day after vaccination, twice a week.
Fig3. In vivo validation of MC38-Stk11-KO in C57BL/6 mice. C57BL/6 mice were inoculated with MC38-Stk11-KO subcutaneously at 1×106 cells/mouse inoculum for tumor development. The day of vaccination for mice is defined as Day 0, and tumor measurement and weight measurement begin on the 3rd day after vaccination, twice a week.
Fig4. Stk11 expression in tumors after in vivo growth of MC38-Stk11-KO in wild type C57BL/6 mice. When the mean tumor volume (MTV) reaches 500-800 mm3, take one tube from each group and send it to Western Blot for testing (Markers: mGapdh, mStk11); When the MTV reaches 1000-1500mm3, take 2 tubes from each group and send them to Western Blot for testing (Markers: mGapdh, mStk11). A, the MTV reaches 800 mm3. B, the MTV reaches 1500 mm3.
You may also like
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreAt GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
Learn more
